Business Context and Reporting Period
Horizon Technology Finance Corporation (HRZN) filed a Current Report on Form 8-K on August 7, 2025. The filing announces the entry into a definitive Merger Agreement with Monroe Capital Corporation (MRCC). Under the agreement, MRCC will merge with and into HRZN, with HRZN continuing as the surviving company. The transaction is structured as a reorganization under Section 368(a) of the Internal Revenue Code and is intended to comply with Rule 17a-8 of the Investment Company Act of 1940.
Key Financial Metrics and Transaction Terms
The filing does not provide specific revenue, profit, cash flow, or debt metrics for the reporting period. The financial terms of the transaction are defined by an exchange ratio based on Net Asset Value (NAV):
- Exchange Ratio: Calculated as the quotient of MRCC Per Share NAV divided by HRZN Per Share NAV, determined as of a date no earlier than 48 hours prior to the Effective Time.
- Consideration: MRCC shareholders will receive HRZN common stock based on the Exchange Ratio, with cash paid in lieu of fractional shares.
- Termination Fees:
- Approximately $11 million payable to MRCC if HRZN is acquired by a third party after termination.
- Approximately $5.4 million payable to HRZN if MRCC is acquired by a third party after termination.
- An additional $5.4 million payable to HRZN if the related Asset Purchase Agreement is terminated and a fee is payable to Monroe Capital Income Plus Corporation (MCIP).
- Advisory Fee Waiver: HRZN Advisor agreed to waive $4.0 million in Base Management and/or Incentive Fees, payable at $1.0 million per quarter for four quarters following the closing of the Mergers.
Material Changes and Transaction Structure
The primary material change is the initiation of the merger process. The transaction involves a two-step merger: first, a wholly-owned subsidiary of HRZN (Merger Sub) merges with MRCC; second, the surviving MRCC merges into HRZN. This structure is contingent upon the consummation of an Asset Sale involving MRCC and MCIP immediately prior to the Merger. The boards of directors of both companies, including special committees of independent directors, have approved the agreement.
Guidance, Outlook, and Risks
Outlook and Timing: Consummation of the Merger is currently anticipated to occur during the fourth quarter of 2025. The transaction is subject to a termination date of February 9, 2026, if not completed by then.
Conditions to Closing: The merger is subject to several conditions, including:
- Requisite approvals from HRZN and MRCC stockholders.
- Effectiveness of the registration statement for HRZN Common Stock to be issued.
- Required regulatory approvals, including the expiration of the Hart-Scott-Rodino waiting period.
- Consummation of the Asset Sale between MRCC and MCIP.
- Absence of legal impediments and accuracy of representations and warranties.
Risks and Contingencies: The filing highlights risks regarding the failure to satisfy closing conditions, potential governmental prohibitions, shareholder litigation, disruption of operations, and changes in economic or regulatory environments. The filing includes standard forward-looking statements disclaiming guarantees regarding the timing or benefits of the transaction.
Investor Verification Checklist
- Verify the final Exchange Ratio once the Determination Date NAV calculations are released.
- Monitor the status of the Asset Sale between MRCC and MCIP, as the Merger is contingent upon its consummation.
- Review the upcoming Joint Proxy Statement and Registration Statement (Form N-14) for detailed financial data and voting procedures.
- Confirm the timeline for stockholder meetings and the receipt of requisite approvals from both HRZN and MRCC shareholders.
- Assess the impact of the $4.0 million advisory fee waiver on future expense ratios and net asset value.